SVG Sprites


Press Release 03.31.2022

LDPN on House Bill: “Half-measures are not enough.”

Statement from Margarida Jorge, head of Lower Drug Prices Now – the leading campaign fighting to lower prescription drug prices – in response to House passage a bill to cap the cost of insulin:

This legislation is a positive step, but it falls far short of the kind of real reform that millions of Americans need for all kinds of health conditions.

Press Release 03.10.2022

LDPN Response To Inflation Report: Time For Congress To Act

This report highlights what we already know: it is far past time for Congress to take immediate action to help lower the costs of everyday things in people’s lives. Congress can and should start with lowering drug prices, a policy that 9 out of 10 voters identify as important in the upcoming elections.

Press Release 03.02.2022

There are 50 votes for prescription drug reform. Call the vote.

We are pleased that President Biden used his State of the Union Address to highlight the need to take action to lower the costs of prescription drugs. Our message to Democrats now is, get it done. Stop talking and start acting.

Press Release 01.31.2022

Rep. Wild Leads Letter Pressuring Leadership to Address Drug Pricing Reforms

Today, Representative Susan Wild (PA-07) led a letter with 40 House Democrats addressed to leadership, urging them to take up legislative action as quickly as possible to lower drug prices.

LDPN In the News 01.19.2022

Sen. Wyden Continues Investigation Into Big Pharma Tax Practices

Not only have Big Pharma corporations raised the prices of more than 450 drugs already this year, but this investigation from Senate Finance shows how they’re using complex loopholes to avoid paying taxes on the sales of those drugs.

Press Release 12.19.2021

Manchin’s opposition to BBB can’t be final word on drug pricing

Senator Manchin’s opposition to Build Back Better is a major blow against lowering prescription drug prices and holding Big Pharma accountable for price gouging. Refusing support for this bill means drug corporations can keep their monopoly power to set prices high and keep raising them even if seniors, patients and families go without life-saving medicines they need. Senator Manchin’s announcement puts him on the wrong side when it comes to affordable prescriptions.

Press Release 12.10.2021

Senators can help stop Pharma’s price gouging practices

We applaud the House Oversight Committee for its three-year investigation, which lays out in detail how Big Pharma’s profit-driven practices are making it harder for families nationwide to afford their prescription drugs, especially in the midst of an ongoing global pandemic. 

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles